Pharmacology, Toxicology and Pharmaceutical Science
Rheumatoid Arthritis
100%
Inflammatory Arthritis
100%
Disease Modifying Antirheumatic Drug
37%
Diseases
29%
Randomized Controlled Trial
22%
Methotrexate
19%
Tumor Necrosis Factor Inhibitor
16%
Remission
15%
Disease Activity
15%
Biological Product
10%
Combination Therapy
10%
Clinical Trial
10%
Disease Activity Score
9%
Glucocorticoid
7%
Placebo
7%
Arthritis
6%
Pharmacotherapy
6%
Monotherapy
6%
Tumor Necrosis Factor
5%
Observational Study
5%
Medicine and Dentistry
Rheumatoid Arthritis
76%
Inflammatory Arthritis
76%
Disease Modifying Antirheumatic Drug
19%
Diseases
17%
Randomized Controlled Trial
17%
TNF Inhibitor
14%
Systematic Review
12%
Disease Activity
11%
Health Assessment Questionnaire
10%
Disease Activity Score
10%
Quality of Life
9%
Methotrexate
8%
Biological Product
6%
Placebo
6%
Leflunomide
5%
Disease-Modifying Antirheumatic Drug
5%
Nursing and Health Professions
Inflammatory Arthritis
66%
Rheumatoid Arthritis
66%
Disease Modifying Antirheumatic Drug
15%
Systematic Review
13%
Disease Activity
12%
Remission
12%
Tumor Necrosis Factor Inhibitor
9%
Disease Activity Score
8%
Diseases
8%
Health Assessment Questionnaire
8%
Biological Product
5%
Practice Guideline
5%
Quality of Life
5%